tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Helsinki
About this trial
The goal of this intervention is to investigate whether transcranial Direct Current Stimulation (tDCS) can alleviate Cancer-Related Cognitive Impairment (CRCI) in breast cancer survivors, as measured by changes in brain structures and cognitive performance. To assess the efficacy of tDCS, the investigators will compare outcomes between participants receiving active stimulation and those receiving sham stimulation (a placebo condition where participants believe they are receiving stimulation, but are not).
Participants will:
* Undergo a baseline MRI session * Receive either active or sham tDCS for six weeks * Undergo a follow-up MRI session * Complete cognitive tests and respond to psychosocial questionnaires before, during, and after the tDCS intervention
Eligibility criteria
Qualifiers
Female
Over 18 years old
Diagnosed with primary adult-onset breast cancer within the last 5 years
Completed all active cancer treatments at least 3 months prior to study participation
Disqualifiers
Have received primary cancer treatment (chemotherapy, radiotherapy, immunotherapy, or surgery) within the last 3 months
Have a history of childhood-onset cancer
Present with acute eczema on the scalp
Diagnosed with dementia, Alzheimer's disease, multiple sclerosis, or - Parkinson's disease
Trial design
Treatments tested in this trial
- active tDCS
- sham tDCS
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov